Societal CDMO Competitors and Similar CompaniesClear all
Societal CDMO's competitors and similar companies include Biofrontera and Amicus Therapeutics.
 Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. |  Biofrontera Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |
Founding Date | Founding Date 2006 | Founding Date 2012 | Founding Date 2002 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Gainesville, US HQ Gainesville, US San Diego, US | Locations Leverkusen, DE HQ | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 21316% decrease | Employees 91 | Employees 58415% increase |
Valuation ($) | Valuation ($) 116.1 m | Valuation ($) 1.1 m | Valuation ($) 3.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) $94.6m (FY, 2023) | Revenue (est.) €13.2m (FY, 2025) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods $76.5m (FY, 2023) | Cost of goods €2.2m (FY, 2025) | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €11.2m (FY, 2025) | Gross profit $561.3m (FY, 2025) |
Net income | Net income ($13.3m) (FY, 2023) | Net income (€6.9m) (FY, 2025) | Net income ($27.1m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biofrontera
HQ
Leverkusen, DE
Employees
91
Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics.
View companyAmicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company